comprehensive -WSS

comprehensive

author：comprehensive 2025-09-06 03:33:22 - browse：654

Stock photo of a surgeon holding a digital tablet in a medical setting – health tech coverage from STAT — Adobe

A new $50 million nonprofit initiative aims to independently evaluate health technologies’ impact on costs and quality, an attempt to help patients, payers, and providers sort over-hyped products from ones that actually move the needle.

The Peterson Center on Healthcare, a nonprofit supporting programs that raise care quality and drive down costs, announced the new Peterson Health Technology Institute Tuesday. The institute plans to publish its methodology for assessing new health technology as soon as September, and start publishing reports on specific sectors, like disease types or tech mechanisms, in 2024, executive director Caroline Pearson told STAT.

Especially after digital health investment surged early in the pandemic, health apps and software have proliferated — both those marketed to consumers and designed for organizations like health systems or insurers. Venture funding has since contracted, but customers are still faced with “an overwhelming number of solutions,” Pearson said. “It’s hard to know what is high value in this space.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Investment in vaccine development is lagging, report finds

WSS

White House pharmacy plagued with problems, investigation finds

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Akili changes sales model for its ADHD video game treatment

Zyn nicotine pouches become unlikely player in latest culture war

White House pharmacy plagued with problems, investigation finds

Assistant physicians can help address the primary care shortage

explore

comprehensive

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Merck, Johnson & Johnson CEOs will testify on high drug prices

United colonoscopy coverage change 'may cost lives,' doctors say

Covid’s new normal has set in amid another rise in cases

Supreme Court strikes down use of affirmative action

Patients, doctors press FTC to beef up hospital merger scrutiny

Drug repurposing or repositioning? The language matters

FDA weighs limits of animal data in assessing artificial wombs

George Santos makes 1st court appearance after pleading not guilty to 13 counts

'A game

Wikipedia

Chamber of Commerce, DOJ clash in court over drug prices

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Assistant physicians can help address the primary care shortage

Fed up with FDA, ALS advocates consider a take

New clues to why women have higher risk of autoimmune disorders

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

focus

entertainment

explore

knowledge